These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 31383846)
21. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study. Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722 [TBL] [Abstract][Full Text] [Related]
22. The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials. Zhang MM; Zou Y; Li SM; Wang L; Sun YH; Shi L; Lu L; Bao YP; Li SX Transl Psychiatry; 2020 Jun; 10(1):193. PubMed ID: 32555188 [TBL] [Abstract][Full Text] [Related]
23. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients. Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567 [TBL] [Abstract][Full Text] [Related]
24. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial. Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655 [TBL] [Abstract][Full Text] [Related]
25. Omega-3 Polyunsaturated Fatty Acids are not associated with Peripheral Artery Disease in a Meta-Analysis from the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities Study Cohorts. Weir NL; Nomura SO; Guan W; Garg PK; Allison M; Misialek JR; Karger AB; Pankow JS; Tsai MY J Nutr; 2024 Jan; 154(1):87-94. PubMed ID: 37940004 [TBL] [Abstract][Full Text] [Related]
26. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial. Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961 [TBL] [Abstract][Full Text] [Related]
27. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression. Su KP Asia Pac J Clin Nutr; 2008; 17 Suppl 1():151-7. PubMed ID: 18296325 [TBL] [Abstract][Full Text] [Related]
28. The Effect of Omega-3 Fatty Acids, EPA, and/or DHA on Male Infertility: A Systematic Review and Meta-analysis. Hosseini B; Nourmohamadi M; Hajipour S; Taghizadeh M; Asemi Z; Keshavarz SA; Jafarnejad S J Diet Suppl; 2019; 16(2):245-256. PubMed ID: 29451828 [TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials. Yang B; Tseng PT; Hu X; Zeng BY; Chang JP; Liu Y; Chu WJ; Zhang SS; Zhou ZL; Chu CS; Chang CH; Tu YK; Wu YC; Stubbs B; Carvalho AF; Lin PY; Matsuoka YJ; Suen MW; Su KP Prog Lipid Res; 2022 Nov; 88():101196. PubMed ID: 36341839 [TBL] [Abstract][Full Text] [Related]
30. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Sarris J; Mischoulon D; Schweitzer I J Clin Psychiatry; 2012 Jan; 73(1):81-6. PubMed ID: 21903025 [TBL] [Abstract][Full Text] [Related]
31. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial. Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463 [TBL] [Abstract][Full Text] [Related]
32. Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial. Zimmer R; Riemer T; Rauch B; Schneider S; Schiele R; Gohlke H; Diller F; Steinbeck G; Katus H; Senges J; J Clin Psychiatry; 2013 Nov; 74(11):e1037-45. PubMed ID: 24330904 [TBL] [Abstract][Full Text] [Related]
33. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Su KP; Lai HC; Yang HT; Su WP; Peng CY; Chang JP; Chang HC; Pariante CM Biol Psychiatry; 2014 Oct; 76(7):559-66. PubMed ID: 24602409 [TBL] [Abstract][Full Text] [Related]
34. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Ross BM; Seguin J; Sieswerda LE Lipids Health Dis; 2007 Sep; 6():21. PubMed ID: 17877810 [TBL] [Abstract][Full Text] [Related]
35. Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Bipolar Disorder: A Review of Biomarker and Treatment Studies. Saunders EF; Ramsden CE; Sherazy MS; Gelenberg AJ; Davis JM; Rapoport SI J Clin Psychiatry; 2016 Oct; 77(10):e1301-e1308. PubMed ID: 27631140 [TBL] [Abstract][Full Text] [Related]
36. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chang JP; Tseng PT; Zeng BS; Chang CH; Su H; Chou PH; Su KP Adv Nutr; 2023 Nov; 14(6):1326-1336. PubMed ID: 37567449 [TBL] [Abstract][Full Text] [Related]
37. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial. Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014 [TBL] [Abstract][Full Text] [Related]
38. A meta-analytic review of polyunsaturated fatty acid compositions in dementia. Lin PY; Chiu CC; Huang SY; Su KP J Clin Psychiatry; 2012 Sep; 73(9):1245-54. PubMed ID: 22938939 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy. Tseng PT; Zeng BS; Suen MW; Wu YC; Correll CU; Zeng BY; Kuo JS; Chen YW; Chen TY; Tu YK; Lin PY; Carvalho AF; Stubbs B; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Wu MK; Shiue YL; Su KP Brain Behav Immun; 2023 Jul; 111():352-364. PubMed ID: 37150266 [TBL] [Abstract][Full Text] [Related]
40. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea. Park Y; Park YS; Kim SH; Oh DH; Park YC Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]